The increasing volume of research investigating essential fatty acids such as DHA and AA sparked the interest of infant nutrition brands and nutraceutical product development firms to explore supplementation strategies for preterm infants. This review summarizes the key research findings that support omega-3 and omega-6 fatty acid supplementation for visual and neurologic development for infants born extremely preterm, and the relevance to current food supplement manufacturing and product innovation.
Fatty Acid Supplementation for Preterm Infants: Bridging Clinical Research and Product Development
The increasing volume of research investigating essential fatty acids such as DHA and AA sparked the interest of infant nutrition brands and nutraceutical product development firms to explore supplementation strategies for preterm infants. This review summarizes the key research findings that support omega-3 and omega-6 fatty acid supplementation for visual and neurologic development for infants born extremely preterm, and the relevance to current food supplement manufacturing and product innovation.
Background
The early birth of extremely preterm infants results in multiple developmental problems because their eyes and brain systems do not develop properly. The medical condition known as retinopathy of prematurity (ROP) threatens vision in premature babies and these patients usually develop permanent visual problems. Research studies have shown that essential fatty acid supplements containing AA and DHA help develop the retina and brain. Despite these benefits, fatty acid supplementation is not routinely administered to extremely preterm infants immediately after birth.
The research examines how AA and DHA supplementation affects visual abilities in preterm babies who were born before 28 weeks of gestation during their first 2.5 years of corrected age. The study examines if the treatment outcomes exist independently from the presence of previous ROP diagnosis relevant to preterm infant nutrition and dietary supplement development.
Preterm babies:
Omeg3-fatty acid and omega6- fatty acid especially for docosahexaenoic acid (DHA) and Arachidonic acid (AA) can reduce the risk of early eye disorder like retinopathy and early visual acuity.[1] An early birth of babies are provide with the supplements combined with omega-3 fatty acids and omega-6 fatty acids to have a better visual function by the two and half years old . it is done by the study in the University of Gothenburg.[2] [3] These insights contribute to advancements in health-conscious product development for neonatal nutrition.
Retinopathy of prematurity (ROP):
Retinopathy of prematurity (ROP) is a serious visual disorder it is one of the abnormal growths in the blood vessels in the retina present in the eye. which is leads to loss of vision. Preterm babies are born extremely before the due date (less than 28 weeks of gestation) have an increased risk of developing Retinopathy of prematurity, according to findings from the Mega Donna Mega study. This long-term visual benefit supports integrating key fatty acids into nutritional supplement development for preterm care.
On these results, lead to author Pia Lundgren, M.D., Ph.D., associate professor in paediatric eye research at the University of Gothenburg and chief physician at Sahlgrenska University Hospital, and her colleagues conducted a follow-up of the Mega Donna Mega trial to determine if the ophthalmological effect of Omega 3- fatty acid and Omega 6- fatty acid (DHA/AA )supplementation in early preterm babies, infants persisted at 2.5 years of corrected age (chronological age minus number of weeks preterm).[4]
Clinical Research Foundation
Study Design and Participants
The research studied 178 preterm babies who needed less than 28 weeks of gestation to receive AA and DHA supplements right after their birth. The research team monitored participants from birth until they reached 2.5 years of corrected age for visual function evaluations. [5]
Intervention
The researchers provided arachidonic acid (omega-6) and docosahexaenoic acid (omega-3) to new-borns as soon as they were born. The two essential fatty acids play a vital role in forming retinal and neural membranes which affect both physical and operational growth.
Outcome Measures
- The main research goal focused on evaluating visual abilities when participants reached 2.5 years of corrected age.
- The study evaluated previous ROP occurrences and their relationship to visual development progress.
- The study faced two major drawbacks because few participants completed visual acuity tests and the statistical analysis had restricted power.
Results:
- The combination of AA and DHA supplements led to significant visual function enhancements when children reached 2.5 years of age based on their corrected birth age.
- The study results showed positive changes in visual function that did not depend on previous ROP diagnosis.
- The research indicates that the supplement helps brain functions which process visual information leading to improved visual interpretation abilities.
- The previous study demonstrated that AA+DHA supplements reduced ROP occurrence by half among the same study participants.
These results reinforce how fatty acid supplementation forms a foundation for infant brain development strategies in both clinical and product design contexts.
The study faced two main challenges because few participants completed visual acuity tests and the analysis had restricted statistical power which requires additional research for confirmation.
Table: Benefits and Mechanisms of Omega-3 and Omega-6 Fatty Acids for Preterm Babies[6]
Benefit | Description |
Improved Visual Development | DHA is a major structural component of the retina and brain, enhancing visual acuity and retinal function. |
Reduced Deficiency Risks | Preterm babies have lower DHA due to early birth; supplementation bridges this gap during critical growth. |
Retinopathy of Prematurity | Omega-3 & Omega-6 supplementation reduces the risk of ROP, a major visual disorder in preterm infants. |
Brain Development | These fatty acids support neural membrane integrity, cognitive functions, and interpretation of visual inputs. |
Immune and Growth Support | Fatty acids regulate intracellular signaling and support overall growth and immune health in infants. |
Mechanisms and Developmental Benefits
Structural component:
Omega3- fatty acid is major structural component of the formation retina and brain for faster and better visual quality [7]
Reduced deficiency of fatty acid:
Extreme preterm babies more often have a deficiency in DHA because they are born before the due date of pregnancy journey a period of rapid in-utero accumulation of these fatty acids. Supplementation helps to bridge this gap [8]
Improved visual activity:
Studies have shown that preterm babies have fed with formula of DHA supplemented formula for two to four months due to corrected age. Preterm infants fed formulas with docosahexaenoic acid (DHA, 22:6n-3) during the interval equivalent to the last intrauterine trimester and beyond have higher circulating DHA and transiently higher visual acuity compared with infants fed formulas containing linolenic acid [9]
Brain development:
Fatty acid is not only improving the eye vision but also it improves the brain development. It helps the baby to interpret the visual signals
Protecting against ROP:
Research study indicates that the combination of Omega 3-fatty acid and Omega 6-fatty acid can have the risk of retinopathhy of prematurity (ROP), it is one of the serious eye diseases occur for preterm babies.[10]
Common market examples for Omega 3 & 6 fatty acid for preterm babies
Driven by clinical evidence, infant nutrition brands now formulate products with balanced DHA and AA ratios to mimic in-utero conditions and enhance preterm outcomes. This alignment between clinical findings and nutraceutical product development promotes healthy outcomes for preterm infants.
Product Name | Key Nutritional Features | Target Age Group | Distinctive Omega-3 and Omega-6 Claims | Brand/Manufacturer |
Progen Advanced Stage 1 Infant Formula | DHA, ARA, iron, and protein-enriched formula | 0–6 months (Stage 1) | Contains DHA and ARA for visual and brain development | Pro-To-Grow |
Similac NeoSure | Optimized nutrient blend with DHA, ARA, and prebiotics | Preterm and low-birth-weight infants (post-discharge) | Clinically shown to improve catch-up growth and visual outcomes | Abbott Nutrition |
Enfamil EnfaCare Infant Formula | High-calorie milk-based formula with DHA, ARA, and choline | Preterm infants | Supports brain, eye, and immune development during recovery | Mead Johnson (Reckitt) |
Aptamil Preterm Infant Formula | Adapted protein and omega fatty acid content for neonatal care | Hospital-fed preterm infants | Balanced DHA:ARA ratio supporting visual and cognitive function | Danone Nutricia |
Product Example: Infant Formula
Product name: Progen Advanced Stage 1 Infant Formula
Product Category: Infant formula Milk based powder
Conclusion:
Research in the clinical setting has demonstrated that Omega-3 (DHA) and Omega-6 (AA) fatty acid supplementation engages advancements in visual and brain development in the preterm population. The examples of Progen Advanced, Similac NeoSure, Enfamil EnfaCare, and Aptamil Preterm product lines demonstrate how brands respond to research in evidence-based infant formula globally. Collectively, these examples illustrate that product formats are changing to evidence-based levels of nutrition that influence visual and neurological outcomes in early neonatal infant care.
Food Research Lab partners with global brands to create, optimize, and validate formulations through tailored nutraceutical product development, dietary supplement development, and regulatory compliance.
Collaborate with Food Research Lab — transforming science into innovation for better infant health worldwide.
Reference:
- Uauy, R., Birch, E., Birch, D., Tyson, J., & Hoffman, D. (1992). Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. American Journal of Clinical Nutrition, 56(6), 1091–1097. https://doi.org/10.1016/S0002-9165(23)19646-8
- University of Gothenburg. (2023, June 1). Preterm babies given certain fatty acids have better vision. https://www.gu.se/en/news/preterm-babies-given-certain-fatty-acids-have-better-vision
- Uauy, R., Birch, E., Birch, D., Tyson, J., & Hoffman, D. (1992). Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. American Journal of Clinical Nutrition, 56(6), 1091–1097. https://pubmed.ncbi.nlm.nih.gov/8317386/
- Managed Healthcare Executive. (2023, June 15). Effects of fatty acid supplementation on vision of preterm babies. https://www.managedhealthcareexecutive.com/view/effects-of-fatty-acid-supplementation-on-vision-of-preterm-babies
- Medical Dialogues. (2023, June 12). Preterm babies have improved eyesight when given certain fatty acids. https://medicaldialogues.in/mdtv/pediatrics-neonatology/videos/preterm-babies-have-improved-eyesight-when-given-certain-fatty-acids-117208
- Koletzko, B., Sauerwald, T., & von Schenck, U. (2016). Fatty acid requirements for the preterm infant. Journal of Pediatrics, 179, 60–66. https://pubmed.ncbi.nlm.nih.gov/27599697/
- Meldrum, S. J., D’Vaz, N., Simmer, K., Middleton, P., & Makrides, M. (2022). n–3 fatty acid supplementation in mothers, preterm infants, and term infants and childhood psychomotor and visual development: A systematic review and meta-analysis. Journal of Nutritional Science, 151(5), 1234–1248. https://doi.org/10.1016/j.jand.2022.109909
- Baack, M. L., & Puumala, S. E. (2015). Beyond building better brains: Bridging the docosahexaenoic acid (DHA) gap of prematurity. Frontiers in Pediatrics, 3, 63. https://pmc.ncbi.nlm.nih.gov/articles/PMC4281288/
- Hoffman, D. R., Birch, E. E., Prestidge, C., & Uauy, R. (1996). Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatric Research, 39, 882–888. https://www.nature.com/articles/pr19962543
- Managed Healthcare Executive. (2023, June 15). Effects of fatty acid supplementation on vision of preterm babies. https://www.managedhealthcareexecutive.com/view/effects-of-fatty-acid-supplementation-on-vision-of-preterm-babies
Let’s create something Innovative and Delicious together
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.